InforCapital

M&A Transaction Database

Diagnostics M&A Transactions

Mergers and acquisitions in the Diagnostics subsector.

Filters

6 shown

Date:Apr 5, 2026
Guardant Health Acquires MetaSight Diagnostics for $150M

Guardant Health boosts liquid biopsy tech with MetaSight Diagnostics acquisition. Deal valued up to $150M, expanding early cancer detection and disease identification.

Acquirer:Guardant Health
Deal Value:n/a
Country:🇮🇱 🇺🇸
Date:Mar 31, 2026
Biogen Acquires Apellis for $5.6B, Boosting Rare Disease Portfolio

Biogen secures Apellis Pharmaceuticals in a $5.6 billion deal, enhancing its immunology and rare disease offerings with two approved therapies and expanding nephrology reach.

Acquirer:Biogen
Deal Value:n/a
Country:🇺🇸
Date:Mar 31, 2026

CareHub

CareHub Expands Italian Diagnostics Network with Acquisitions

CareHub, supported by Quadrivio Group, grows its Italian diagnostic clinics through multiple acquisitions, aiming for significant revenue growth and market leadership.

Acquirer:—
Deal Value:n/a
Country:🇮🇹
Date:Mar 28, 2026
Vimian Group Acquires Italian Veterinary Diagnostics Firm

Vimian Group AB enhances its companion animal diagnostics capabilities by acquiring I-Vet and Biofleet in Italy, a strategic move in a growing market.

Acquirer:Vimian Group
Deal Value:n/a
Country:🇮🇹
Date:Mar 23, 2026

Medisolve

Medisolve Acquires Spanish Imaging Firm, Expands European Reach

Medisolve, with H.I.G. Capital's backing, acquires CEDYT Sistemas Diagnosticos, enhancing its diagnostic imaging services and exceeding 180M euros in revenue.

Acquirer:—
Deal Value:n/a
Country:🇪🇸
Date:Mar 21, 2026
Solabia Acquires SEQENS Botanical & IVD Units

Solabia Group, with Astorg's backing, strengthens its cosmetic ingredients and diagnostics portfolio by acquiring key divisions from SEQENS.

Acquirer:Solabia Group
Deal Value:n/a
Country:🇫🇷

Never Miss a Deal

Get weekly investment intelligence. Free forever.

You reached the end (6 deals).